
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a commercial-stage biopharmaceutical company based in Brisbane, California, is making waves in the biotechnology sector with an impressive 83.9% revenue growth. Specializing in the..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a burgeoning player in the biotechnology industry, is capturing the attention of investors with its promising drug pipeline and a significant potential upside of 58.63%...
Neuropace, Inc. (NASDAQ: NPCE), a key player in the healthcare sector, specifically within the medical devices industry, is catching investor attention with a compelling potential upside of 45.50%. Headquartered in..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company based in New Haven, Connecticut, is currently making waves in the biotechnology industry. With a robust market capitalization of $1.52 billion,..
Investors with an eye on Cronos Group Inc. (NASDAQ: CRON) are witnessing an intriguing narrative unfold in the burgeoning cannabis sector. As a key player in the healthcare industry, specifically..
Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the medical devices industry, has been capturing investor attention with its promising potential upside of 34.04%. Headquartered in Burlington, Massachusetts, the..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is making waves in the biotechnology sector with its promising outlook for investors. With a market capitalization of $1.52 billion, Iovance is positioned at the..
Evolus, Inc. (NASDAQ: EOLS) is a name that might not instantly ring a bell for every investor, yet it has carved a niche for itself within the vibrant healthcare sector,..
Avanos Medical, Inc. (NYSE: AVNS), a key player in the medical devices sector, offers investors a unique blend of opportunities and challenges. With a market capitalization of $644.13 million, this..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company rooted in the heart of San Diego, California, is capturing the attention of investors with its robust pipeline and impressive growth metrics...
Nuvation Bio Inc. (NASDAQ: NUVB), a promising player in the biotechnology sector, has captured investor attention with a striking potential upside of 161.44%. This clinical-stage biopharmaceutical company is on an..
RxSight, Inc. (NASDAQ: RXST), a pioneering medical technology company specializing in light adjustable intraocular lenses (LAL) for cataract surgery, finds itself at a crucial juncture. With a current market capitalization..
Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is capturing investor attention as it targets rare respiratory diseases. With a market capitalization of $1.07 billion, the company is focused on..
For investors with an eye on the biotechnology sector, Bicycle Therapeutics plc (NASDAQ: BCYC) presents an intriguing opportunity. With a market capitalization of $313.68 million and a substantial potential upside..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a San Diego-based biotechnology company, is capturing investor attention with a notable potential upside of 40.24%, as suggested by its current analyst ratings. Despite..
For investors seeking a high-risk, high-reward opportunity within the biotechnology sector, LENZ Therapeutics, Inc. (NASDAQ: LENZ) presents a compelling case. This innovative company, headquartered in Solana Beach, California, focuses on..
InMode Ltd. (NASDAQ: INMD), an innovative player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with a notable 23.64% potential upside, according to analyst targets...
Pharvaris N.V. (PHVS), a Swiss-based biotechnology company, is capturing investor attention with its promising potential upside of 67.65%. Specializing in therapies for rare bradykinin-mediated diseases, Pharvaris is advancing its late-stage..
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is capturing investor attention with a potential upside of 100.05%, as highlighted by recent analyst ratings. This Chicago-based biopharmaceutical company is dedicated to advancing..




